Liver Disease Drug Pulled From the Market

(MedPage Today) — Intercept Pharmaceuticals has pulled obeticholic acid (Ocaliva) from the U.S. market as a treatment for primary biliary cholangitis (PBC) after the FDA requested its removal and placed ongoing trials on clinical hold.
The move…